The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Aerosol Therapy Market Insights and Sales Trends 2024

Aerosol Therapy Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1854645

No of Pages : 102

Ask Your Query

Synopsis

Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices. This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.

The global Aerosol Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Aerosol Therapy in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgical Centers and Individual, are propelling Aerosol Therapy market. Inhalers, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nebulizers segment is estimated at % CAGR for the next seven-year period.

Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Aerosol Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Aerosol Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Aerosol Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Aerosol Therapy sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Aerosol Therapy covered in this report include Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare and Medtronic, etc.

The global Aerosol Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Merck
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • AstraZeneca
  • Novartis
  • Teva Pharmaceuticals
  • Opko Health
  • Omron Healthcare
  • Medtronic
  • GE Healthcare
  • Philips Healthcare
  • Agilent Technologies
  • GF Health Products

Global Aerosol Therapy market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Aerosol Therapy market, Segment by Type:

  • Inhalers
  • Nebulizers
  • Bronchodilators

Global Aerosol Therapy market, by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Individual

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Aerosol Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Aerosol Therapy
1.1 Aerosol Therapy Market Overview
1.1.1 Aerosol Therapy Product Scope
1.1.2 Aerosol Therapy Market Status and Outlook
1.2 Global Aerosol Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Aerosol Therapy Market Size by Region (2018-2029)
1.4 Global Aerosol Therapy Historic Market Size by Region (2018-2023)
1.5 Global Aerosol Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Aerosol Therapy Market Size (2018-2029)
1.6.1 North America Aerosol Therapy Market Size (2018-2029)
1.6.2 Europe Aerosol Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Aerosol Therapy Market Size (2018-2029)
1.6.4 Latin America Aerosol Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Aerosol Therapy Market Size (2018-2029)
2 Aerosol Therapy Market by Type
2.1 Introduction
2.1.1 Inhalers
2.1.2 Nebulizers
2.1.3 Bronchodilators
2.2 Global Aerosol Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Aerosol Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Aerosol Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Aerosol Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Aerosol Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Aerosol Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Aerosol Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Aerosol Therapy Revenue Breakdown by Type (2018-2029)
3 Aerosol Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.1.4 Individual
3.2 Global Aerosol Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Aerosol Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Aerosol Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Aerosol Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Aerosol Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Aerosol Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Aerosol Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Aerosol Therapy Revenue Breakdown by Application (2018-2029)
4 Aerosol Therapy Competition Analysis by Players
4.1 Global Aerosol Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aerosol Therapy as of 2022)
4.3 Date of Key Players Enter into Aerosol Therapy Market
4.4 Global Top Players Aerosol Therapy Headquarters and Area Served
4.5 Key Players Aerosol Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Aerosol Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Aerosol Therapy Products, Services and Solutions
5.1.4 Merck Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Aerosol Therapy Products, Services and Solutions
5.2.4 Boehringer Ingelheim Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 GlaxoSmithKline
5.3.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline Aerosol Therapy Products, Services and Solutions
5.3.4 GlaxoSmithKline Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Aerosol Therapy Products, Services and Solutions
5.4.4 AstraZeneca Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Aerosol Therapy Products, Services and Solutions
5.5.4 Novartis Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Teva Pharmaceuticals
5.6.1 Teva Pharmaceuticals Profile
5.6.2 Teva Pharmaceuticals Main Business
5.6.3 Teva Pharmaceuticals Aerosol Therapy Products, Services and Solutions
5.6.4 Teva Pharmaceuticals Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Teva Pharmaceuticals Recent Developments
5.7 Opko Health
5.7.1 Opko Health Profile
5.7.2 Opko Health Main Business
5.7.3 Opko Health Aerosol Therapy Products, Services and Solutions
5.7.4 Opko Health Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Opko Health Recent Developments
5.8 Omron Healthcare
5.8.1 Omron Healthcare Profile
5.8.2 Omron Healthcare Main Business
5.8.3 Omron Healthcare Aerosol Therapy Products, Services and Solutions
5.8.4 Omron Healthcare Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Omron Healthcare Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic Aerosol Therapy Products, Services and Solutions
5.9.4 Medtronic Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Medtronic Recent Developments
5.10 GE Healthcare
5.10.1 GE Healthcare Profile
5.10.2 GE Healthcare Main Business
5.10.3 GE Healthcare Aerosol Therapy Products, Services and Solutions
5.10.4 GE Healthcare Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 GE Healthcare Recent Developments
5.11 Philips Healthcare
5.11.1 Philips Healthcare Profile
5.11.2 Philips Healthcare Main Business
5.11.3 Philips Healthcare Aerosol Therapy Products, Services and Solutions
5.11.4 Philips Healthcare Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Philips Healthcare Recent Developments
5.12 Agilent Technologies
5.12.1 Agilent Technologies Profile
5.12.2 Agilent Technologies Main Business
5.12.3 Agilent Technologies Aerosol Therapy Products, Services and Solutions
5.12.4 Agilent Technologies Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Agilent Technologies Recent Developments
5.13 GF Health Products
5.13.1 GF Health Products Profile
5.13.2 GF Health Products Main Business
5.13.3 GF Health Products Aerosol Therapy Products, Services and Solutions
5.13.4 GF Health Products Aerosol Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 GF Health Products Recent Developments
6 North America
6.1 North America Aerosol Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Aerosol Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Aerosol Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Aerosol Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Aerosol Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Aerosol Therapy Market Dynamics
11.1 Aerosol Therapy Industry Trends
11.2 Aerosol Therapy Market Drivers
11.3 Aerosol Therapy Market Challenges
11.4 Aerosol Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock